DocDollars

Sunovion Pharmaceuticals Inc.

MA · United States · Reporting entity ID 100000000254

Total reported 2019–2025
$65.4M
#140 of 2,960 reporting companies — 0.1% of all reported industry payments
$15.9M in general payments across 379,785 records, plus $49.5M in research funding across 13,455 records.

How it breaks down

General payments $15,889,007
Research funding $49,501,514

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sunovion Pharmaceuticals Inc. reported $65.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #140 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 379,785 general payment records and 13,455 research records were filed.

Common questions about Sunovion Pharmaceuticals Inc.

How much has Sunovion Pharmaceuticals Inc. paid US doctors?

Sunovion Pharmaceuticals Inc. reported $65,390,520 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $15,889,007 in general payments, $49,501,514 in research funding.

How does Sunovion Pharmaceuticals Inc. rank among drug and device companies?

It ranks #140 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Sunovion Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.